Delivery Order SPE2DR25D6028-SPE2DR26FATGP
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,662.56 to AmerisourceBergen Drug Corp for phenazopyridine hydrochloride on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,070.28 to AmerisourceBergen Drug Corp for the supply of Phenazopyridine Hydrochloride, a urinary analgesic pharmaceutical product. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of December 16, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively made with no...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp for $2,078.96 to supply Phenazopyridine 200 mg tablets in quantities of 100 units. The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a small-value pharmaceutical transaction supporting federal medical procurement needs. This delivery order was executed without a set-aside designation and will be performed at the awardee's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenazopyridine 200 mg tablets (100 count) under a firm fixed-price contract valued at $2,463.42, with an ultimate completion date of August 7, 2025. This non-set-aside award was issued on August 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,056.24 award is for the supply of 4,564,169,902 tablets of the drug Phenazopyridine 200 mg, a urinary analgesic, to support military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract, valued at $1,119.66, is for the supply of 100 mg tablets of the drug phenazopyridine in 100 count bottles. The delivery order has a period of performance through March 29, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,914.65, is for the delivery of 4,566,420,936 tablets of Phenazopyridine 200 mg. The contract is a firm fixed-price delivery order with a completion date of November 14, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a substantial...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 4,564,205,494 units of the pharmaceutical drug Phenazopyridine 100 mg tablets in 100-count bottles. The total ceiling value of the order is $2,692.96, with a period of performance through April 9, 2024. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The order is for the supply of Phenazopyridine 200 mg tablets, a medication, and has a potential value of $2,782.65. The order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency awarded a $818.04 delivery order to Amerisourcebergen Drug Corporation for 200mg phenazopyridine tablets. Under the firm fixed price contract, Amerisourcebergen will deliver 100 count bottles of the medication to a location in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite delivery/indefinite quantity contract vehicle....
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATGPDelivery Order
The Defense Logistics Agency awarded a $1,942.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phenazopyridine Hydrochloride, with an ultimate completion date of January 30, 2026. This non-set-aside contract was competitively awarded on January 2, 2026, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Phenazopyridine hydrochloride is a urinary analgesic commonly used to relieve dysuria and other urinary tract symptoms, making this delivery order consistent with the Defense Logistics Agency's medical supply chain requirements for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent IDC enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/1/26 |